Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- REG1V.HE
- Price
- 23.25
- Stock movement down
- -0.40 (-1.69%)
- Company name
- Revenio Group Corporation
- Exchange
- (HE ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Devices
- Market cap
- 618.36M
- Ent value
- 633.06M
- Price/Sales
- 6.18
- Price/Book
- 6.33
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- 113.38%
- Trailing P/E
- 31.86
- Forward P/E
- 24.18
- PEG
- -
- EPS growth
- 16.27%
- 1 year return
- -9.74%
- 3 year return
- -20.93%
- 5 year return
- -0.59%
- 10 year return
- 13.24%
Last updated: 2025-04-12
DIVIDENDS
REG1V.HE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 31.86 |
| Price to OCF | 28.24 |
| Price to FCF | 35.54 |
| Price to EBITDA | 25.98 |
| EV to EBITDA | 26.60 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 6.18 |
| Price to Book | 6.33 |
| EV to Sales | 6.32 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 26.60M |
| EPS (TTM) | 0.73 |
| FCF per share (TTM) | 0.65 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 100.10M |
| Gross profit (TTM) | 65.00M |
| Operating income (TTM) | 26.00M |
| Net income (TTM) | 19.41M |
| EPS (TTM) | 0.73 |
| EPS (1y forward) | 0.96 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 64.94% |
| Operating margin (TTM) | 25.97% |
| Profit margin (TTM) | 19.39% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 18.30M |
| Net receivables | 13.30M |
| Total current assets | 42.00M |
| Goodwill | 59.50M |
| Intangible assets | 18.60M |
| Property, plant and equipment | 5.20M |
| Total assets | 130.70M |
| Accounts payable | 13.20M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 19.40M |
| Total liabilities | 33.00M |
| Shareholder's equity | 97.70M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 21.90M |
| Capital expenditures (TTM) | 4.50M |
| Free cash flow (TTM) | 17.40M |
| Dividends paid (TTM) | 19.73M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 19.87% |
| Return on Assets | 14.85% |
| Return on Invested Capital | 19.87% |
| Cash Return on Invested Capital | 17.81% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 23.60 |
| Daily high | 23.60 |
| Daily low | 22.25 |
| Daily Volume | 21K |
| All-time high | 70.70 |
| 1y analyst estimate | 32.75 |
| Beta | 1.34 |
| EPS (TTM) | 0.73 |
| Dividend per share | - |
| Ex-div date | 5 Apr 2024 |
| Next earnings date | 23 Apr 2025 |
Downside potential
Loading...
Downside potential data
| REG1V.HE | S&P500 | |
| Current price drop from All-time high | -67.11% | -12.89% |
| Highest price drop | -88.84% | -56.47% |
| Date of highest drop | 28 Dec 2004 | 9 Mar 2009 |
| Avg drop from high | -38.98% | -11.07% |
| Avg time to new high | 33 days | 12 days |
| Max time to new high | 1446 days | 1805 days |
COMPANY DETAILS
Marketcap
618.36M
Marketcap category
Small-cap
Description
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, rest of Europe, North America, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; and iCare TONOVET an IOP measuring on animal patients by general veterinary practitioners, veterinary ophthalmologists, and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON AF, a device with confocal retinal imaging; and DRSplus, a device for pupil imaging; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. In addition, the company offers Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.
Employees
230
Website
Investor relations
-
SEC filings
CEO
Country
Finland
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
The European market has recently seen mixed performances, with the pan-European STOXX Europe 600 Index edging up by 0.56% amid hopes for increased government spending, although concerns over U.S. tari...
March 28, 2025
As global markets show signs of optimism with cooling inflation and strong earnings reports, major U.S. stock indexes have rebounded, particularly favoring value stocks over growth shares. In this env...
January 21, 2025
In the current global market environment, characterized by cautious Federal Reserve commentary and looming political uncertainties, investors are navigating a landscape of mixed economic signals. Desp...
December 23, 2024
As global markets react to the recent U.S. election results and economic policy shifts, major indices like the S&P 500 have reached record highs, fueled by investor optimism around potential growth an...
November 13, 2024
Revenio Group Oyj (FRA:R0V) reports a 14.2% increase in net sales and a 25.6% rise in EBITDA, showcasing robust financial health despite competitive pressures.
October 9, 2024